Tevogen Bio Holdings Inc (TVGN)
R&D Expense Growth
4.71%
Quarterly · Period ending:
TVGN R&D Expense Growth
Latest reported4.71%period ending
Latest reported4.71%period ending
TVGN Quarterly R&D Growth (QoQ) (0.00% → 4.71%)
Latest values, visible window
High-resolution chart · PNG
TVGN r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 4.7131% | |
| 48.8673% | |
| -32.3066% | |
| 15.2134% | |
| -15.495% | |
| 12.6489% | |
| -13.0218% | |
| -20.9364% | |
| -80.1819% | |
| 2,191.9008% | |
| -18.7% | |
| 8.2915% | |
| -23.4402% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |